IRIS
BELLISAI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.126
EU - Europa 4.107
AS - Asia 2.396
SA - Sud America 373
AF - Africa 119
Continente sconosciuto - Info sul continente non disponibili 103
OC - Oceania 10
AN - Antartide 1
Totale 13.235
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.027
RU - Federazione Russa 930
SG - Singapore 874
CN - Cina 748
GB - Regno Unito 686
IE - Irlanda 533
IT - Italia 510
SE - Svezia 349
BR - Brasile 311
DE - Germania 288
UA - Ucraina 264
FR - Francia 236
VN - Vietnam 211
HK - Hong Kong 178
FI - Finlandia 165
KR - Corea 98
IN - India 70
CA - Canada 59
ZA - Sudafrica 52
BD - Bangladesh 49
ES - Italia 37
IQ - Iraq 25
CI - Costa d'Avorio 20
AR - Argentina 19
JP - Giappone 19
MX - Messico 17
PL - Polonia 17
NL - Olanda 16
TR - Turchia 16
AT - Austria 14
BE - Belgio 14
CZ - Repubblica Ceca 13
MA - Marocco 13
PK - Pakistan 13
EC - Ecuador 12
IR - Iran 11
NG - Nigeria 11
UZ - Uzbekistan 10
CO - Colombia 9
NP - Nepal 9
PH - Filippine 9
AU - Australia 8
SA - Arabia Saudita 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
IL - Israele 6
LT - Lituania 6
TN - Tunisia 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EG - Egitto 5
JO - Giordania 5
KE - Kenya 5
KG - Kirghizistan 5
UY - Uruguay 5
GR - Grecia 4
JM - Giamaica 4
PY - Paraguay 4
BS - Bahamas 3
HR - Croazia 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
IM - Isola di Man 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
OM - Oman 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
DK - Danimarca 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 13.128
Salva come PNG Salva come JPEG
Città #
Dallas 926
Menlo Park 785
Singapore 611
Southend 588
Dublin 523
Ashburn 444
Fairfield 355
San Jose 317
Chandler 287
Santa Clara 287
Moscow 257
Jacksonville 204
Beijing 195
Hong Kong 173
Woodbridge 172
Milan 156
Wilmington 137
Houston 135
Seattle 133
Hefei 122
Ann Arbor 116
Council Bluffs 110
Cambridge 109
Princeton 97
Seoul 97
Los Angeles 94
New York 93
Helsinki 90
The Dalles 88
Munich 81
Rome 73
Ho Chi Minh City 72
Nanjing 72
Siena 60
Lauterbourg 55
Hanoi 48
Johannesburg 44
San Mateo 37
Boardman 36
Dearborn 35
Buffalo 34
São Paulo 30
Columbus 28
Shanghai 26
Turku 26
Nanchang 25
San Diego 24
Orem 23
Chicago 22
Abidjan 20
Brooklyn 20
Frankfurt am Main 20
London 20
Denver 18
Tokyo 18
Düsseldorf 17
Montreal 17
Málaga 17
Chennai 16
Florence 16
Stockholm 16
Warsaw 16
Bengaluru 15
Shenyang 15
Washington 15
Atlanta 14
Brussels 14
Dong Ket 14
San Francisco 14
Toronto 14
Venezia 14
Figino 13
Hebei 13
Changsha 12
Jinan 12
Redondo Beach 12
Rio de Janeiro 12
Tianjin 12
Vienna 12
Abuja 11
Guangzhou 11
Baghdad 10
Da Nang 10
Mumbai 9
Ningbo 9
Nuremberg 9
Phoenix 9
Tashkent 9
Belo Horizonte 8
Brno 8
Haiphong 8
Mexico City 8
Portsmouth 8
Fremont 7
Guayaquil 7
Kunming 7
Lappeenranta 7
Philadelphia 7
Amsterdam 6
Boston 6
Totale 9.184
Salva come PNG Salva come JPEG
Nome #
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 370
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 318
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 314
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 310
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 306
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 302
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 301
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 301
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 297
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 289
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 282
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 275
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 273
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 272
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 263
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 260
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 259
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 255
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 255
Chromosome aberrations in Raynaud's phenomenon 253
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 252
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 246
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 237
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 234
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 225
Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes 225
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 220
Anterior chest wall non-traumatic diseases: A road map for the radiologist 220
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 215
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 214
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 212
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 208
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 206
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 204
HCV e malattie autoimmuni 202
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 196
Treatment strategies for apatient with rheumatoid arthritis and hepatitis C 192
Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study 188
Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm 187
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 184
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 181
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 180
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 177
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 176
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection 176
Low muscle mass and body composition analysis in a group of postmenopausal women affected by primary Sjögren’s syndrome 169
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 168
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 166
Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection 164
Simultaneouspulmonary involvement, histologically proven, of sarcoidosis and rheumatoidarthritis. 163
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 162
Associazione interferon α2b e ciclosporina A nel trattamento dell'epatite cronica C: Trial controllato 161
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients. 157
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 154
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 150
Le indicazioni al trattamento con immunoglobuline endovena nella sindrome da anticorpi antifosfolipidi. [Indications for intra-venous immunoglobulins treatment in the antiphospholipid syndrome] 141
La tipizzazione genetica nelle malattie reumatiche autoimmuni e nelle sindromi autoinflammatorie 138
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 120
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. 111
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease 100
null 99
Totale 13.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022561 0 0 44 77 27 16 30 20 30 65 88 164
2022/20231.061 67 105 151 147 104 211 16 87 104 22 28 19
2023/2024838 36 16 77 78 28 230 279 9 3 10 11 61
2024/20251.725 35 89 203 81 225 93 65 87 124 80 215 428
2025/20264.868 333 607 756 558 1.050 241 476 88 129 211 80 339
2026/2027437 147 127 163 0 0 0 0 0 0 0 0 0
Totale 13.235